We are constantly looking for opportunities to exchange and develop ideas, as they are the foundation for scientific advances and innovation. In addition to our collaboration with academic and commercial partners, attending conferences such as Knowledge for Growth provides us with insights and connections that help us improve our current offerings.
InnoSer is eager to be present at this exciting event organized by Flanders Bio, where we will be happy to discuss our services aimed at accelerating preclinical research. Our Business Development Managers are looking forward to connecting with other life science enthusiasts both at the exhibition but also in meetings with swapcard.
InnoSer has a wide portfolio of in vivo and in vitro services which can be customized to your research project and specific needs. Our various methods can also be combined to improve the reliability and transferability of your data, which is especially important to avoid low success rates in drug development. Besides, Innoser offers not only reliable platforms for drug screening but also facility management services and support with scientific expertise. We are specialized in oncology, polycystic kidney disease, neurodegenerative diseases and cardio-metabolic diseases.
Support in drug development
Outside of our disease specific models and therapeutic expertise InnoSer can provide general contract research services to a range of therapeutic areas. With our fully equipped facilities we are capable of supporting tailored and customized options to support your project no matter your field of interest. Below is a selection of services that could support your research goals and milestones.
Pharmacology/efficacy studies and customized offerings
- Safety, tolerability and toxicology
- PK/PD studies
- Patient-derived xenografts and organoids
- 2D cell culture
- Disease model development
- Medical device testing
Providing high-quality readouts and facility management services
- Implantation of tumors
- Contract breeding
- Live cell imaging
- Bioluminescent imaging
- Flow cytometry
You can find an overview of our offerings at https://www.innoserlaboratories.com/services/ Interested in getting to know the full scope of our services that support drug development at Knowledge for Growth? We encourage you to book a meeting now using swapcard and get in touch with one of our Business Development Managers. See you soon!
Missed the event but still interested?
Want to read more?
Modelling neurodegenerative disease using in vitro assays Neurodegenerative drug development is held back due to the lack of appropriate models that help accelerate the pace at which novel therapeutic candidates move through the drug development pipeline. As such, in...
Delayed-type hypersensitivity (DTH) in vivo assay represents a relatively quick and useful approach for evaluating the efficacy of potential immunomodulatory or immunosuppressive compounds. By challenging the cell-mediated immune response, you obtain valuable...
At InnoSer, we offer several readouts to assess the disease progression and the efficacy of novel targeted polycystic kidney disease (PKD) compounds. However, we understand that it remains a significant challenge to access crucial readouts that are recognized by...